Sundise Chinese Medicine Technology Development Co. Selects Medidata Solutions, Inc. to Drive Entry into U.S. Market

6/11/2010 9:31:57 AM

NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that Traditional Chinese Medicine (TCM) company Sundise will implement Medidata Rave® as its electronic data capture (EDC) and clinical data management (CDM) solution. Selected for its ability to offer a broad global reach with local in-country support, Medidata will work with Sundise to conduct its first U.S. trial for its TCM treatment for liver fibrosis and will play a key role in supporting the company’s strategy to launch in the U.S.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Medidata Solutions, Inc.

• Sundise Chinese Medicine Technology Development Co.

• Biotech/Pharma - Software

• Biotech/Pharma - Software (World)